| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |